sb 203580 has been researched along with aphidicolin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (aphidicolin) | Trials (aphidicolin) | Recent Studies (post-2010) (aphidicolin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,647 | 3 | 136 |
| Protein | Taxonomy | sb 203580 (IC50) | aphidicolin (IC50) |
|---|---|---|---|
| DNA polymerase catalytic subunit | Human alphaherpesvirus 1 strain KOS | 0.438 | |
| DNA polymerase catalytic subunit | Human alphaherpesvirus 1 strain 17 | 0.5 | |
| DNA polymerase catalytic subunit | Human herpesvirus 5 strain AD169 | 0.4435 | |
| DNA polymerase catalytic subunit | Human herpesvirus 3 strain Dumas | 1.6 | |
| DNA polymerase alpha catalytic subunit | Homo sapiens (human) | 2.98 | |
| DNA polymerase catalytic subunit | Human herpesvirus 6 (strain Uganda-1102) | 0.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balmanno, K; Cook, SJ; Garner, AP; Todd, DE; Weston, CR | 1 |
1 other study(ies) available for sb 203580 and aphidicolin
| Article | Year |
|---|---|
Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Topics: Animals; Aphidicolin; Apoptosis; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cells, Cultured; Cricetinae; Cyclin A; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Methylation; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; G1 Phase; G2 Phase; Gene Silencing; Genes, Synthetic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 3; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 11; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Sequence Deletion; Tamoxifen | 2002 |